Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
| Image |  |
|---|---|
| Description | scientific article published in September 2017 |
| Author/s |
author: Vajir Malek |
| Publication date | September 1, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |